Quantitative Ultrasound to Assess Steatotic Liver Disease in Children

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

September 23, 2024

Primary Completion Date

February 28, 2029

Study Completion Date

June 30, 2029

Conditions
MASLDMASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Interventions
DIAGNOSTIC_TEST

MR exam

Participants will undergo an advanced magnetic resonance (MR) examination of the abdomen and liver.

DIAGNOSTIC_TEST

US exam

Participants will undergo an abdominal ultrasound (US) examination using a full-size US system. Some participants may undergo a point-of-care abdominal US exam with a handheld US system, if possible.

OTHER

Blood draw

Participants will undergo a blood draw of approximately 25 mL volume.

OTHER

Physical measurements

Participants will have their height, weight and waist circumference measured. Vital signs including respiratory frequency, heart rate, temperature, and blood pressure will be measured.

OTHER

Questionnaires

Participants will be asked to fill out questionnaires to collect information about their prescribed medications, demographics, medical and surgical histories, prior laboratory results, physical activity and lifestyle measures, and potential alcohol intake (AUDIT questionnaire).

Trial Locations (1)

92037

RECRUITING

University of California San Diego, La Jolla

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Virginia Polytechnic Institute and State University

OTHER

collaborator

GE Healthcare

INDUSTRY

lead

University of California, San Diego

OTHER